Genelux Corporation (GNLX) financial statements and ratios from SEC XBRL: revenue $8000.00 (TTM), net margin -401812.5%, revenue growth 0.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $8000.00 |
| Net Margin | -401812.5% |
| Revenue Growth (YoY) | 0.0% |
| EPS Growth (YoY) | -9.5% |
| FCF Growth (YoY) | 22.0% |
| Price / Book | 7.61 |
| Price / Sales | 189.22 |
| FCF Yield | -39.7% |
| Altman Z-Score | -16.33 (distress) |
| Sector P/E (Healthcare) | 21.7 |
GNLX overview · GNLX earnings · GNLX KPIs · GNLX investor relations · GNLX ownership · GNLX peers · GNLX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.